Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Pharmacology and Clinical Pharmacy Research
M, Kiran
Unknown Affiliation
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Rabeprazole and Domperidone Induced Hyperprolactinemia in a Patient with Type 2 Diabetes Mellitus, Hypothyroidism and Peptic Ulcer Disease: A Case Report M, Kiran; Chakraborty, Ananya
Pharmacology and Clinical Pharmacy Research Vol 9, No 3 (2024)
Publisher : Universitas Padjadjaran, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15416/pcpr.v9i3.54359

Abstract

Drugs are a common cause of hyperprolactinemia. They are common in patients taking antipsychotics, antiemetics, opioids, antidepressants, prokinetics and proton pump inhibitors (PPI). Rabeprazole is a relatively newer PPI. Domperidone is a well-known prokinetic and antiemetic drug.  There are few reports of hyperprolactinemia & galactorrhea with fixed drug combination (FDC) of rabeprazole (20 mg) and domperidone (30 mg). Here, we report a case of 39-year-old diabetic and hypothyroid female patient who was on the above FDC for peptic ulcer disease on and off for the last four years and developed hyperprolactinemia. She showed neither clinical signs of galactorrhea nor amenorrhea. On routine blood investigations, she had increased prolactin level. Radiological evaluation of brain was normal. The drug was stopped and repeat prolactin was normal within one week of withholding. A diagnosis of rabeprazole and domperidone induced hyperprolactinemia was reached based on clinical, laboratory judgement and causality assessment.
Co-Authors Chakraborty, Ananya